| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 37.040 | 45.131 | 56.160 | 61.279 | 47.529 | 38.685 | 29.397 | - | - |
| Total Income - EUR | 0 | 37.248 | 45.506 | 56.208 | 61.348 | 47.529 | 38.685 | 29.397 | - | - |
| Total Expenses - EUR | 919 | 23.060 | 40.509 | 33.722 | 48.138 | 38.479 | 25.947 | 25.077 | - | - |
| Gross Profit/Loss - EUR | -919 | 14.188 | 4.997 | 22.486 | 13.210 | 9.051 | 12.738 | 4.320 | - | - |
| Net Profit/Loss - EUR | -1.043 | 13.027 | 4.034 | 21.923 | 12.590 | 8.623 | 11.716 | 3.441 | - | - |
| Employees | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | - | - |
Check the financial reports for the company - Aliruxia Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.785 | 3.639 | 3.803 | 3.306 | 3.140 | 2.981 | 2.818 | 2.730 | - | - |
| Current Assets | 0 | 29.339 | 6.676 | 21.121 | 16.552 | 20.453 | 38.409 | 39.606 | - | - |
| Inventories | 0 | 0 | 0 | 2.147 | 3.100 | 5.314 | 13.778 | 13.073 | - | - |
| Receivables | 0 | 0 | 0 | 773 | 4.742 | 4.878 | 5.946 | 5.951 | - | - |
| Cash | 0 | 29.339 | 6.676 | 18.201 | 8.709 | 10.262 | 18.685 | 20.583 | - | - |
| Shareholders Funds | 2.634 | 15.634 | 9.991 | 23.711 | 18.429 | 11.469 | 22.931 | 26.443 | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | 1.151 | 17.344 | 488 | 716 | 1.263 | 11.965 | 18.296 | 15.893 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6201 - 6201" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Aliruxia Srl